Topical tacrolimus in the management of lichen sclerosus
Authors:
- 22 June 2006
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 113 (7) , 832-834
Abstract
The effective management of vulval lichen sclerosus (LS) currently depends upon the use of topical steroids and emollients. There are concerns with regard to the long‐term toxicity of potent steroids and therefore is a need to consider effective alternatives. Immunomodulatory macrolactams offer an alternative to steroids in the management of some other inflammatory skin disorders and it would seem reasonable therefore to assess their activity in LS. This pilot study of 16 histologically confirmed cases of LS suggests that macrolactams have a positive pharmacological effect.Keywords
This publication has 3 references indexed in Scilit:
- Successful Treatment of Anogenital Lichen Sclerosus With Topical TacrolimusArchives of Dermatology, 2003
- Tacrolimus ointment for the treatment of vulvar lichen sclerosusJournal of the American Academy of Dermatology, 2003
- Macrolactam immunomodulators for topical treatment of inflammatory skin diseasesJournal of the American Academy of Dermatology, 2001